Metraipolis › archive › dc_288467da8366
Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and… — Europe PMC PMID:41875066
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41875066
- DOI
- 10.2478/raon-2026-0015
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T01:27:50.597Z
- SHA-256 of the archived text
8ee3718626d9bc291227153807a30cf21b670eb6ba428fbf459352de89ef4d9b- Stable URL of this page
https://metraipolis.com/documento/dc_288467da8366
How to cite
Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and… — Europe PMC PMID:41875066 — Europe PMC (en), https://europepmc.org/article/MED/41875066 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_288467da8366 (Metraipolis archive dc_288467da8366, sha256 8ee3718626d9bc291227153807a30cf21b670eb6ba428fbf459352de89ef4d9b)
BibTeX
@misc{dc288467da8366,
title = {Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and… — Europe PMC PMID:41875066},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41875066},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_288467da8366; sha256 8ee3718626d9bc291227153807a30cf21b670eb6ba428fbf459352de89ef4d9b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41875066. Agents can read the archived copy with the MCP tool read_document.